Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Hip Recall Litigation
Date:12/6/2013

New York, New York (PRWEB) December 06, 2013

Thousand of DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) filed on behalf of individuals who allegedly suffered metallosis, pseudotumors, premature device failure and other complications caused by the recalled devices are continuing to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio, Bernstein Liebhard LLP reports. According to an Order filed on December 5, 2013, the Court has amended an earlier Case Management Order pertaining to the Defendants’ Master Answer. Among other things, the new Order Stipulates that the Master Answer is now deemed filed and immediately applicable and responsive to all DePuy ASR lawsuits claims currently pending in the litigation. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“Our Firm is representing hundreds of DePuy ASR lawsuit clients in this litigation. We are currently working to assist our clients who may be eligible for the recently announced DePuy ASR settlement to determine their best course of action,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who may have been harmed by devices included in the DePuy ASR recall.

DePuy ASR Settlement
The issuance of this new Order follows the November 19th announcement in the Northern District of Ohio of a proposed agreement to settle many of the DePuy ASR lawsuits now pending in courts around the country. According to court documents, if the settlement is accepted by at least 94% of eligible plaintiffs, those claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience “certain extraordinary injuries” in the future. Those eligible for the proposed DePuy ASR settlement include recipients of the recalled hip who had an ASR hip replaced for a reason related to the recall no later than August 31, 2013.

According to The New York Times, if the DePuy ASR settlement is finalized, it could resolve roughly 8,000 of the 12,000 claims filed against Johnson & Johnson and DePuy Orthopaedics since the hip recall was announced in 2010. Those who are not eligible for compensation under its terms may still pursue DePuy ASR lawsuits against the company.*

Recipients of ASR hips who suffered serious complications that may have been caused by the device are urged to contact Bernstein Liebhard LLP today to learn more about the proposed settlement, or to discuss their legal options for filing their own DePuy ASR lawsuit. To learn more about the DePuy ASR recall, please visit the Firm’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*nytimes.com/2013/11/20/business/johnson-johnson-to-offer-2-5-billion-hip-device-settlement.html, New York Times, November 20, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-settlement/prweb11400412.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Hip Settlement News: Number of Federal Pinnacle Cases Now Exceeds 5,000, Rottenstein Law Group LLP Reports
2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Order Delaying Consideration of Remand Motions in Federal Pinnacle Hip Litigation
3. DePuy Pinnacle Lawsuit Claims Mount, as Bernstein Liebhard LLP Notes Nearly 6,000 Filings in Federal Pinnacle Hip Litigation
4. DePuy ASR Lawsuit Settlement Update: Rottenstein Law Group LLP Comments on Report of Proposed Additional Compensation
5. DePuy Settlement Update: DePuy Pinnacle Lawsuits Progress in Federal Court, Rottenstein Law Group LLP Reports
6. DePuy ASR Lawsuit Settlement Update: Retired Judge Selected As Claims Administrator, Rottenstein Law Group LLP Reports
7. DePuy ASR™ MDL Lawsuit Update: Settlement Reached in the DePuy ASR™ Hip Implant Multidistrict Litigation (MDL 2197)
8. Chicago Personal Injury Firm of Salvi, Schostok and Pritchard P.C. Calls Attention to Proposed $2.5 Billion DePuy Hip Implant Settlement
9. DePuy ASR Lawsuit Settlement Proposal Moves Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Recall Litigation
10. DePuy ASR Settlement News: Bernstein Liebhard LLP Notes Appointment of Special Masters, Claims Administrator to Oversee Proposed DePuy ASR Lawsuit Settlement
11. DePuy ASR Lawsuit Settlement News: Johnson & Johnson Deal Still Leaves Opportunity to File Lawsuits, Notes Rottenstein Law Group LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: